ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated. If you have any questions, please contact Marianne Reed at .

Show simple item record

dc.contributor.advisorAudus, Kenneth L
dc.contributor.authorMitra, Pallabi
dc.description.abstractThe trophoblast cell layer constitutes the rate-determining barrier for trans-placental transfer. Several isoforms of the sulfotransferase enzymes are functional in placenta but there is only limited information available on the utility of cultured trophoblast cells for studying placental sulfation. We examined the expression and activities of four sulfotransferase isoforms (SULT1A1, SULT1A3, SULT1E1, and SULT2A1) in primary cytotrophoblast cells and the trophoblast-like BeWo cell line. These isoforms have been reported to be functional in human placenta. Our results indicated that the phenolic sulfotransferase isoforms, SULT1A1 and SULT1A3, are functional in BeWo, as well as in the primary cytotrophoblast cells. SULT2A1 and SULT1E1 are not functional in either cell type. We also found that chronic exposure to the industrial chemical bisphenol A inhibited SULT1A1 activity. A U-shaped dose-response curve was observed with inhibition (~30-40%) being observed only at intermediate concentrations (10-100 nM). These results suggested that trophoblast cells may be used as a suitable in vitro tool to determine the effect of endogenous or exogenous substances on placental sulfotransferase activity. Altered metabolic activity has the chance of altering fetal exposure to drugs and other substances in the maternal circulation. Studies performed in BeWo cells also suggested that one of the roles of the placental efflux transporters is the elimination of sulfate metabolites. The multidrug resistance-associated proteins (MRPs) played a major role in the elimination of 4-nitrophenyl sulfate and acetaminophen sulfate across the basolateral (fetal-facing) and apical (maternal-facing) trophoblast membranes respectively. The breast cancer resistance protein (BCRP) played a minor role in the elimination of these two sulfate conjugates across the apical membrane.
dc.format.extent189 pages
dc.publisherUniversity of Kansas
dc.rightsThis item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
dc.subjectPharmaceutical chemistry
dc.subjectBisphenol a
dc.subjectBreast cancer resistance protein (bcrp)
dc.subjectMultidrug resistance-associated protein (mrp)
dc.subjectSulfotransferase enzymes
dc.contributor.cmtememberKrise, Jeffrey P.
dc.contributor.cmtememberLunte, Susan M.
dc.contributor.cmtememberSiahaan, Teruna J.
dc.contributor.cmtememberSoares, Michael J
dc.thesis.degreeDisciplinePharmaceutical Chemistry

Files in this item


This item appears in the following Collection(s)

Show simple item record